stars 1 stars 2 stars 3

RxSight is a medical device company dedicated to transforming cataract surgery outcomes through the power of adjustability. The company makes the Light Adjustable Lens™ (LAL®), the only FDA-approved intraocular lens (IOL) that can be customized after cataract surgery using ultraviolet (UV) light treatments. Unlike traditional IOLs—which are fixed at the time of implantation—the LAL allows the treating physician to fine-tune the lens prescription after the eye has fully healed. This means patients receive a vision outcome tailored to their actual, post-surgical visual needs rather than a pre-surgical estimate. RxSight (Nasdaq: RXST) works with cataract surgeons and ophthalmologists to bring this personalized approach to vision care. For physicians, the LAL platform provides a clinical differentiation that no other premium IOL can match.

RxSight, Inc. Questions

The RxSight, Inc. annual revenue was $139.9 million in 2026.

Mark Wilterding Jr. is the CFO of RxSight, Inc..

270 people are employed at RxSight, Inc..

RxSight, Inc. is based in Aliso Viejo, California.

Top RxSight, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users